Related Experiment Video
Updated: Nov 10, 2025
Isolating Human Peripheral Blood Mononuclear Cells and CD4+ T cells from Sézary Syndrome Patients for Transcriptomic Profiling
Published on: October 14, 2021
Clinical and Biological Prognostic Factors in Follicular Lymphoma
Anand A Patel1, Sonali M Smith2
1Department of Medicine, Section of Hematology-Oncology, University of Chicago, 5841 South Maryland Avenue, Room E-212A, MC2115, Chicago, IL 60637, USA. Electronic address: https://twitter.com/Anand_88_Patel.
Abstract:
Follicular lymphoma comprises approximately 20-30% of all cases of B-cell lymphomas. Median survival has improved significantly in the modern era. Prognostic factors include histologic grade, cytogenetics, molecular mutations, the tumor microenvironment, and tumor burden. Clinical prognostic indices are available and increasingly incorporate genetic information. Prognostic factors also arise during the course of treatment. Early progression within 24 months of initial chemoimmunotherapy is an adverse prognostic marker of inferior survival. Other high-risk populations include those with double refractory disease or those with high risk of transformation to diffuse large B-cell lymphoma.
